Assessing the cost-effectiveness of annual COVID-19 booster vaccination in South Korea using a transmission dynamic model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Wongyeong | - |
dc.contributor.author | Shim, Eunha | - |
dc.date.accessioned | 2024-01-15T01:00:50Z | - |
dc.date.available | 2024-01-15T01:00:50Z | - |
dc.date.issued | 2023-11 | - |
dc.identifier.issn | 2296-2565 | - |
dc.identifier.issn | 2296-2565 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/48975 | - |
dc.description.abstract | IntroductionWe evaluated the cost-effectiveness of South Korea's planned annual coronavirus disease 2019 (COVID-19) booster campaign scheduled for October 2023.Materials and methodsAn age-structured mathematical model was used to analyze the public impacts and cost-effectiveness of vaccination across three vaccination strategies: uniform allocation and prioritizing those over 65 or those over 50 years old. We calculated the incremental cost per quality-adjusted life year (QALY) from both healthcare and societal perspectives. The maximum vaccine cost for cost-effectiveness was also identified.ResultsOur analysis highlights the cost-effectiveness of South Korea's annual COVID-19 vaccination program in mitigating health and economic impacts. The most cost-effective strategy is uniform vaccine allocation, offering the lowest incremental cost-effectiveness ratio (ICER) at US$ 25,787/QALY. However, with a relatively high attack rate, the strategy prioritizing individuals over 65 years emerges as more cost-effective, lowering the ICER to US$ 13,785/QALY. Prioritizing those over 50 was less cost-effective. All strategies were cost-saving from a societal perspective, with cost-effectiveness being more sensitive to vaccine price than to its effectiveness.DiscussionOur results imply a potential strategy shift in current vaccination plan, with uniform vaccine distribution being more cost-effective than prioritizing older adults. Early estimation of viral transmissibility and vaccine effectiveness is crucial in determining the most cost-effective vaccine allocation approach. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.title | Assessing the cost-effectiveness of annual COVID-19 booster vaccination in South Korea using a transmission dynamic model | - |
dc.type | Article | - |
dc.identifier.doi | 10.3389/fpubh.2023.1280412 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN PUBLIC HEALTH, v.11 | - |
dc.identifier.wosid | 001115134500001 | - |
dc.identifier.scopusid | 2-s2.0-85178924151 | - |
dc.citation.title | FRONTIERS IN PUBLIC HEALTH | - |
dc.citation.volume | 11 | - |
dc.identifier.url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1280412/full | - |
dc.publisher.location | 스위스 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | coronavirus disease | - |
dc.subject.keywordAuthor | COVID-19 vaccine | - |
dc.subject.keywordAuthor | annual vaccination | - |
dc.subject.keywordAuthor | South Korea | - |
dc.subject.keywordAuthor | cost-effectiveness | - |
dc.subject.keywordAuthor | mathematical modeling | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Soongsil University Library 369 Sangdo-Ro, Dongjak-Gu, Seoul, Korea (06978)02-820-0733
COPYRIGHT ⓒ SOONGSIL UNIVERSITY, ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.